Selected research
Market Structure
Global Ranitidine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ranitidine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ranitidine include GSK, Sun Pharma, Merck, Tocris Bioscience (R & D Systems), Strides Pharma Science Limited (Strides Shasun) and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ranitidine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ranitidine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ranitidine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ranitidine market size, projected growth trends, production technologies, key applications, and end-use industries.
Ranitidine Segment by Company
GSK
Sun Pharma
Merck
Tocris Bioscience (R & D Systems)
Strides Pharma Science Limited (Strides Shasun)
Boehringer Ingelheim
Ranitidine Segment by Type
Tablet
Syrup
Injection
Ranitidine Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Ranitidine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ranitidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ranitidine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ranitidine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ranitidine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranitidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ranitidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ranitidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Syrup
- Injection
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- GSK
- Sun Pharma
- Merck
- Tocris Bioscience (R & D Systems)
- Strides Pharma Science Limited (Strides Shasun)
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ranitidine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ranitidine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ranitidine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ranitidine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ranitidine Market Dynamics
- 2.1 Ranitidine Industry Trends
- 2.2 Ranitidine Industry Drivers
- 2.3 Ranitidine Industry Opportunities and Challenges
- 2.4 Ranitidine Industry Restraints
3 Ranitidine Market by Manufacturers
- 3.1 Global Ranitidine Revenue by Manufacturers (2021-2026)
- 3.2 Global Ranitidine Sales by Manufacturers (2021-2026)
- 3.3 Global Ranitidine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ranitidine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ranitidine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ranitidine Manufacturers, Product Type & Application
- 3.7 Global Ranitidine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ranitidine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ranitidine Players Market Share by Revenue in 2025
- 3.8.3 2025 Ranitidine Tier 1, Tier 2, and Tier 3
4 Ranitidine Market by Type
- 4.1 Ranitidine Type Introduction
- 4.1.1 Tablet
- 4.1.2 Syrup
- 4.1.3 Injection
- 4.2 Global Ranitidine Sales by Type
- 4.2.1 Global Ranitidine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ranitidine Sales by Type (2021-2032)
- 4.2.3 Global Ranitidine Sales Market Share by Type (2021-2032)
- 4.3 Global Ranitidine Revenue by Type
- 4.3.1 Global Ranitidine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ranitidine Revenue by Type (2021-2032)
- 4.3.3 Global Ranitidine Revenue Market Share by Type (2021-2032)
5 Ranitidine Market by Application
- 5.1 Ranitidine Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Ranitidine Sales by Application
- 5.2.1 Global Ranitidine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ranitidine Sales by Application (2021-2032)
- 5.2.3 Global Ranitidine Sales Market Share by Application (2021-2032)
- 5.3 Global Ranitidine Revenue by Application
- 5.3.1 Global Ranitidine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ranitidine Revenue by Application (2021-2032)
- 5.3.3 Global Ranitidine Revenue Market Share by Application (2021-2032)
6 Global Ranitidine Sales by Region
- 6.1 Global Ranitidine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ranitidine Sales by Region (2021-2032)
- 6.2.1 Global Ranitidine Sales by Region (2021-2026)
- 6.2.2 Global Ranitidine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ranitidine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ranitidine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ranitidine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ranitidine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ranitidine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ranitidine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ranitidine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ranitidine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ranitidine Revenue by Region
- 7.1 Global Ranitidine Revenue by Region
- 7.1.1 Global Ranitidine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ranitidine Revenue by Region (2021-2026)
- 7.1.3 Global Ranitidine Revenue by Region (2027-2032)
- 7.1.4 Global Ranitidine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ranitidine Revenue (2021-2032)
- 7.2.2 North America Ranitidine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ranitidine Revenue (2021-2032)
- 7.3.2 Europe Ranitidine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ranitidine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ranitidine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ranitidine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ranitidine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Company Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Ranitidine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GSK Ranitidine Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Sun Pharma
- 8.2.1 Sun Pharma Company Information
- 8.2.2 Sun Pharma Business Overview
- 8.2.3 Sun Pharma Ranitidine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharma Ranitidine Product Portfolio
- 8.2.5 Sun Pharma Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Ranitidine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Ranitidine Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Tocris Bioscience (R & D Systems)
- 8.4.1 Tocris Bioscience (R & D Systems) Company Information
- 8.4.2 Tocris Bioscience (R & D Systems) Business Overview
- 8.4.3 Tocris Bioscience (R & D Systems) Ranitidine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Tocris Bioscience (R & D Systems) Ranitidine Product Portfolio
- 8.4.5 Tocris Bioscience (R & D Systems) Recent Developments
- 8.5 Strides Pharma Science Limited (Strides Shasun)
- 8.5.1 Strides Pharma Science Limited (Strides Shasun) Company Information
- 8.5.2 Strides Pharma Science Limited (Strides Shasun) Business Overview
- 8.5.3 Strides Pharma Science Limited (Strides Shasun) Ranitidine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Strides Pharma Science Limited (Strides Shasun) Ranitidine Product Portfolio
- 8.5.5 Strides Pharma Science Limited (Strides Shasun) Recent Developments
- 8.6 Boehringer Ingelheim
- 8.6.1 Boehringer Ingelheim Company Information
- 8.6.2 Boehringer Ingelheim Business Overview
- 8.6.3 Boehringer Ingelheim Ranitidine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Boehringer Ingelheim Ranitidine Product Portfolio
- 8.6.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ranitidine Value Chain Analysis
- 9.1.1 Ranitidine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ranitidine Production Mode & Process
- 9.2 Ranitidine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ranitidine Distributors
- 9.2.3 Ranitidine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst